Results 171 to 178 of about 4,014 (178)

Sofosbuvir and Velpatasvir for Patients With HCV Infection

New England Journal of Medicine, 2016
Masad Barhoum, Stefan Zeuzem, Mark Sulkowski   +2 more
exaly  

Efficacy of the Combination of Sofosbuvir, Velpatasvir, and the NS3/4A Protease Inhibitor GS-9857 in Treatment-Naïve or Previously Treated Patients With Hepatitis C Virus Genotype 1 or 3 Infections

Gastroenterology, 2016
Robert N. Hyland, Evguenia Svarovskaia, Diana M Brainard   +2 more
exaly  

Sofosbuvir/Velpatasvir Concentrations in the Breastmilk of Postpartum Women With Opioid Use Disorder Receiving Treatment for Hepatitis C Virus: A Pharmacokinetic Study

Clinical Infectious Diseases
Elizabeth E Krans, Kristina M Brooks, Catherine A Chappell   +2 more
exaly  

Ribavirin/sofosbuvir/velpatasvir

Reactions Weekly, 2020
openaire   +1 more source

Sofosbuvir/velpatasvir/voxilaprevir

Reactions Weekly, 2019
openaire   +1 more source

Ribavirin/sofosbuvir/velpatasvir

Reactions Weekly, 2019
openaire   +1 more source

Ribavirin/sofosbuvir/velpatasvir

Reactions Weekly
openaire   +2 more sources

PROCESS FOR THE PREPARATION OF VELPATASVIR

2017
VADALI LAKSHMANA RAO, JAYACHANDRA SURESHBABU, PONDURI RAJASEKHAR, PADALA BHASKAR RAO, YERVA ESWARA REDDY, VEMAVARAPU GOVARDHANA PHANI SHARMA, JALDU RAVIKANTH, DANDALA RAMESH   +7 more
openaire   +1 more source